Last reviewed · How we verify

NCT03688217: MOVIE

The Philani Mobile Video Intervention for Exclusive Breastfeeding (MOVIE) Study

Completed NA Last updated 22 October 2020
What this trial tests

NA trial testing Philani Intervention Model+MOVIE (PIM+M) in Exclusive Breastfeeding in 1,504 participants. Completed in 31 March 2020.

Timeline
5 November 2018
Primary endpoint
31 March 2020
31 March 2020

Quick facts

Lead sponsorCharles G. Prober
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeprevention
Enrollment1,504
Start date5 November 2018
Primary completion31 March 2020
Estimated completion31 March 2020
Sites1 location across South Africa

Drugs / interventions tested

Conditions studied

Sponsor

Charles G. Prober

Who can join

18 and older, female only, with Exclusive Breastfeeding or Infant Feeding Practices. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This cluster-randomized controlled trial seeks to evaluate the impact of a mobile video intervention for exclusive breastfeeding (MOVIE) on the infant feeding practices of mothers living in under-resourced communities in the Western Cape, South Africa. The trial will compare infant feeding practices in two groups of participants, enrolled in the Philani Mentor-Mother Outreach Program, a home-visiting program focused on community-based health promotion through peer-to-peer counseling. The participants in the intervention arm will receive the Philani Intervention Model (PIM), a perinatal health promotion intervention, together with the additional mobile, video intervention for exclusive breastfeeding. The participants in the control arm will receive only the standard PIM. Participants will be exposed to either the intervention or the control condition during pregnancy and the first five months after delivery. The central hypothesis in this trial is that, when compared with the control group, infant feeding practices in the intervention group will be significantly better aligned with current World Health Organization recommendations, after exposure to the Philani MOVIE intervention. The primary outcomes in this study are short-term exclusive breastfeeding, in the first month of life, and long-term exclusive breastfeeding, in the fifth month of life, (based on maternal 24-hour recall). Secondary outcomes include other infant feeding practices, such as early initiation of breastfeeding, any breastfeeding in the first month and in the fifth month of life, bottle-feeding, early introduction of complementary foods in the first month and in the fifth month of life and maternal knowledge in the first month and the fifth month post delivery.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Targeted client communication via mobile devices for improving maternal, neonatal, and child health.
    Palmer MJ, Henschke N, Bergman H, Villanueva G, et al · · 2020 · cited 30× · PMID 32813276 · DOI 10.1002/14651858.cd013679
  2. Evaluation of a community-based mobile video breastfeeding intervention in Khayelitsha, South Africa: The Philani MOVIE cluster-randomized controlled trial.
    Adam M, Johnston J, Job N, Dronavalli M, et al · · 2021 · cited 19× · PMID 34582438 · DOI 10.1371/journal.pmed.1003744
  3. The Philani MOVIE study: a cluster-randomized controlled trial of a mobile video entertainment-education intervention to promote exclusive breastfeeding in South Africa.
    Adam M, Tomlinson M, Le Roux I, LeFevre AE, et al · · 2019 · cited 19× · PMID 30940132 · DOI 10.1186/s12913-019-4000-x

Verify or expand the search:

Other recruiting trials for Exclusive Breastfeeding

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03688217.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing